Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus

OBJECTIVE: Benaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that has been approved in the treatment of type 2 diabetes mellitus (T2DM). It is known to lead to significant weight loss, and it is hypothesized that changes in gut microbiota may play a significant role in such weight...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Chen-Yu, Ye, Xiao-Mei, Lu, Jia-Ping, Jin, Hai-Ying, Wang, Ping, Xu, Wei-Wei, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416789/
https://www.ncbi.nlm.nih.gov/pubmed/37577040
http://dx.doi.org/10.2147/DMSO.S418757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416789/
https://www.ncbi.nlm.nih.gov/pubmed/37577040
http://dx.doi.org/10.2147/DMSO.S418757

Ejemplares similares